Bifidobacterium Longum for Cognitive Function

Research suggests that Bifidobacterium longum may support cognitive function across several populations, with evidence spanning randomized controlled trials in healthy older adults and post-stroke patients as well as a range of preclinical and mechanistic studies in animals and cell models. The RCTs generally point in a supportive direction, reporting improvements in memory, attention, mental flexibility, and executive function alongside biological changes such as increased BDNF levels, reduced inflammatory markers, and shifts in gut microbiota composition, while one trial in Alzheimer's patients using a multi-strain formula found promising biological changes but no statistically significant cognitive improvement, reflecting the mixed picture that can emerge in more severely affected populations. Studies indicate that proposed mechanisms involve the gut-brain axis, particularly the reduction of gut-derived inflammatory signals like lipopolysaccharide, enhancement of intestinal barrier integrity, and modulation of microbial communities linked to neuroinflammation and neuroprotection. However, most RCTs included small sample sizes and short durations, the majority of mechanistic research comes from animal or in vitro models that may not translate directly to humans, and several studies examined B. longum in combination with other probiotic strains, making it difficult to attribute effects to this organism alone — meaning the current body of evidence, while encouraging, should be considered preliminary.